Xanthic Biopharma Inc. (d.b.a. Green Growth Brands) Announces Name Change to Green Growth Brands Inc.
Innovation Pharmaceuticals Receives New Brilacidin Patent, Further Expanding Intellectual Property Estate
U.S. Food and Drug Administration Approves Portola Pharmaceuticals’ Prior Approval Supplement for Andexxa
Net Element Launches Multi-Channel Blockchain-Powered Payments Acceptance Application as Part of its Netevia Platform
Quebec Precious Metals Agrees to Extend Work Commitment Deadline to December 31, 2019 for Lomiko to Earn 100% of La Loutre Graphite Property
BriaCell Announces Switch to Novel Frozen Formulation for Lead Cancer Drug Candidate, Upcoming Attendance at Biotech Showcase™ 2019 and Presentation at Keystone Symposia Conference